Product Data Sheet

THR-β agonist 8

Catalog No. A85476

main product photo
THR-β agonist 8 is an orally active agonist targeting thyroid hormone receptors TRα and TRβ. It demonstrates significant potential in modulating thyroid hormone signaling pathways, making it a valuable tool for investigating thyroid hormone-related diseases. This compound may aid in the understanding of metabolic regulation and therapeutic strategies for thyroid disorders.
Chemical Information
Catalog NumA85476
M. Wt431.23
FormulaC19H12Cl2N4O4
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2832859-77-3
Synonyms
SMILESN#CC1=NN(C2=CC(Cl)=C(C(Cl)=C2)OC3=CC=C(C(C(C)=C)=C3)O)C(NC1=O)=O
Biological Activity
DescriptionTHR-β agonist 8 is an orally active agonist targeting thyroid hormone receptors TRα and TRβ. It demonstrates significant potential in modulating thyroid hormone signaling pathways, making it a valuable tool for investigating thyroid hormone-related diseases. This compound may aid in the understanding of metabolic regulation and therapeutic strategies for thyroid disorders.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.